JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1993) 138, 149-157    DOI: 10.1677/joe.0.1380149
© 1993 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perkins, A. V.
Right arrow Articles by Linton, E. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Perkins, A. V.
Right arrow Articles by Linton, E. A.

Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy

A. V. Perkins, F. Eben, C. D. A. Wolfe, H. M. Schulte and E. A. Linton

Using corticotrophin-releasing hormone-binding protein (CRHBP) purified from human plasma and a 25 amino acid peptide corresponding to the C-terminus of CRHBP we have been able to produce rabbit polyclonal antisera specific for CRHBP. This has allowed the development of a radioimmunoassay which is able to detect CRHBP specifically in human plasma regardless of the presence of endogenous CRH. We have used this assay to estimate the level of CRHBP in non-pregnant human plasma to be approximately 20 nmol/l with a range of 9·1–40·6 nmol/l. We have also examined sequential plasma samples taken from 84 normal pregnant women at fortnightly intervals from 16 weeks gestation through to term. Four women were also sampled during labour and the first week postpartum. The median plasma level of CRHBP at week 16 of normal pregnancy was 21·59 nmol/l, levels rose slightly during the early part of the third trimester (26·76 nmol/l at week 30, (P < 0·01) and fell markedly towards term (19·72 nmol/l, P < 0·01) with only 8·70 nmol/l at labour. CRHBP levels returned to normal non-pregnant levels within 48 h of parturition suggesting a role for the fetoplacental unit in CRHBP production. In eight pregnancies complicated by diabetes, CRHBP levels at each gestational age were similar to those recorded for normal pregnancy. However, in pregnancies complicated by pre-term labour (n = 9) and pre-eclampsia (n = 7), plasma CRHBP levels were significantly reduced (P < 0·01).

Journal of Endocrinology (1993) 138, 149–157




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
P Florio, P J Lowry, C Benedetto, L Galleri, M Torricelli, A Giovannelli, R Battista, F M Reis, and F Petraglia
Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: effect of prostaglandin administration
Eur. J. Endocrinol., September 1, 2007; 157(3): 279 - 284.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
K. S. Rehman, R. Sirianni, C. R. Parker JR, W. E. Rainey, and B. R. Carr
The Regulation of Adrenocorticotrophic Hormone Receptor by Corticotropin-Releasing Hormone in Human Fetal Adrenal Definitive/Transitional Zone Cells
Reproductive Sciences, September 1, 2007; 14(6): 578 - 587.
[Abstract] [PDF]


Home page
Mol Hum ReprodHome page
M.P. Johnson, E. Fitzpatrick, T.D. Dyer, J.B.M. Jowett, S.P. Brennecke, J. Blangero, and E.K. Moses
Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach
Mol. Hum. Reprod., January 1, 2007; 13(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Ahmed, B. P. Glynn, A. V. Perkins, M. G. Castro, J. Rowe, E. Morrison, and E. A. Linton
Processing of Procorticotropin-Releasing Hormone (Pro-CRH): Molecular Forms of CRH in Normal and Preeclamptic Pregnancy
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 755 - 764.
[Abstract] [Full Text]


Home page
J Biomol ScreenHome page
Y. E. Tian, L.-H. Wu, W. T. Mueller, and F.-Z. Chung
A Screening Strategy Based on Differential Binding of Ligand to Receptor and to Binding Proteins: Screening for Compounds Interacting with Corticotrophin-Releasing Factor-Binding Protein
J Biomol Screen, December 1, 1999; 4(6): 319 - 326.
[Abstract] [PDF]


Home page
Mol Hum ReprodHome page
H. Kobayashi, G. W. Sun, and T. Terao
Urinary trypsin inhibitor down-regulates hyaluronic acid fragment-induced prostanoid release in cultured human amnion cells by inhibiting cyclo-oxygenase-2 expression
Mol. Hum. Reprod., July 1, 1999; 5(7): 662 - 667.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
F. M. Reis, M. Fadalti, P. Florio, and F. Petraglia
Putative Role of Placental Corticotropin-Releasing Factor in the Mechanisms of Human Parturition
Reproductive Sciences, May 1, 1999; 6(3): 109 - 119.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Florio, R. J. Woods, A. R. Genazzani, P. J. Lowry, and F. Petraglia
Changes in Amniotic Fluid Immunoreactive Corticotropin-Releasing Factor (CRF) and CRF-Binding Protein Levels in Pregnant Women at Term and during Labor
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 835 - 838.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Society for Endocrinology.